Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety and Immunogenicity of Recombinant (E. Coli) Hepatitis E Vaccine（Hecolin®） in Seniors Aged Over 65 Years

NCT02189603 is registered in ClinicalTrials.gov with Jun Zhang as lead sponsor.

NCT NCT02189603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02189603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety and Immunogenicity of Recombinant (E. Coli) Hepatitis E Vaccine（Hecolin®） in Seniors Aged Over 65 Years
Lead sponsor
Jun Zhang
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2014
Completion date
December 7, 2015
Enrollment
601 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis e